← FDA Drug Approvals (Drugs@FDA)

UKONIQ

NDA · New Drug Application · Sponsor: TG THERAPS · Approved 2021-02-05

Drug application

FDA Application #

NDA213176

Application type

New Drug Application

Brand name

UKONIQ

Generic name

Umbralisib Tosylate

Active ingredients

UMBRALISIB TOSYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

TG THERAPS

First approval

2021-02-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown